FAIR VALUE MEASUREMENT - Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions		12 Months Ended
	Mar. 02, 2021 USD ($)	Dec. 31, 2024 USD ($) shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2024 $ / shares	Apr. 06, 2023 $ / shares shares	Nov. 30, 2022 USD ($)	Nov. 30, 2022 CAD ($) $ / shares	Nov. 14, 2022 USD ($)	Nov. 14, 2022 CAD ($) $ / shares	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain on initial investment in unconsolidated entity		$ 0	$ 10,700
Investment in unconsolidated entity		10,800	11,000
Debt interest rate conversion feature		$ 1,023	872
Derivative Asset, Statement of Financial Position [Extensible Enumeration]		SBH purchase option and other derivative assets
Debt conversion option		$ 786	3,213
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Derivative and other long-term liabilities
Purchase option	$ 8,000
Purchase option, term	5 years
Purchase option, extension term	2 years
Percentage of outstanding shares	10.00%
Warrants expiration period										60 days
Loss on change in fair value of purchase option		$ 1,678	570
Business combination, purchase option		$ 52	$ 1,730
DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership percentage		50.00%
British American Tobacco | DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units ownership percentage		100.00%
AJNA Biosciences | DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership percentage		50.00%
DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants outstanding (in shares) | shares		4,000,000	400,000
Stock split, conversion ratio		0.1
Change in fair value of financial instruments		$ (200)	$ 300
Investment in unconsolidated entity		$ 10,800	$ 11,000
DeFloria, LLC | Common Class A
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares) | shares					865,052
Warrants exercise price (in cad or usd per share) | $ / shares					$ 2.89
DeFloria, LLC | British American Tobacco
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units (in shares) | shares		2,000,000	200,000
Capital contributed		$ 10,000
Payment for convertible debt		5,000
DeFloria, LLC | AJNA Biosciences
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment for convertible debt		$ 2,000
Warrants outstanding (in shares) | shares		4,000,000	400,000
Debt Conversion Option
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain (loss) on hedging instruments		$ 2,265	$ 10,080
Debt conversion option		786	3,213
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entity		10,800	11,000
Debt interest rate conversion feature		1,023	872
Debt conversion option		0	0
Business combination, purchase option		52	1,730
Debt Interest Rate Conversion Feature
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain (loss) on hedging instruments		$ 228	(471)
BAT Group
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible, ownership percentage of shares (as a percent)		19.90%				19.90%	19.90%	19.90%	19.90%
Conversion price (in CAD per share) | $ / shares				$ 2.00			$ 2.00		$ 2.00
BAT Group | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accrued interest rate, percentage						5.00%	5.00%	5.00%	5.00%
BAT Group | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accrued interest rate, percentage						1.50%	1.50%	1.50%	1.50%
Convertible Notes Payable | BAT Group
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount		$ 58,172	$ 60,116			$ 56,800	$ 75.3	$ 56,800	$ 75.3